Once-weekly diabetes drug gets funding

Health minister Sussan Ley has announced the September PBS listing of Bydureon (exenatide), a once weekly treatment for type 2 patients.

It will be competing with and probably replacing the only other PBS-listed exenatide product, Byetta, which requires twice-daily as opposed to weekly injections.

Ms Ley says the new listing means patients will avoid 13 injections a week and will therefore be much more likely to